The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abivax SA 00370M103 00370M103 44,821,601 336,347 SH SOLE 336,347 0 0
Aclaris Therapeutics Inc 00461U105 00461U105 5,514,650 1,042,467 SH SOLE 1,042,467 0 0
Adlai Nortye Ltd 00704R109 00704R109 22,267,347 1,936,291 SH SOLE 1,936,291 0 0
Annexon Inc 03589W102 03589W102 20,238,261 3,544,354 SH SOLE 3,544,354 0 0
Aktis Oncology, Inc. 01021M104 01021M104 155,860,155 4,835,872 SH SOLE 4,835,872 0 0
Alumis Inc 022307102 022307102 56,815,223 2,019,020 SH SOLE 2,019,020 0 0
Belite Bio Inc 07782B104 07782B104 21,127,974 137,208 SH SOLE 137,208 0 0
BIOAGE Labs Inc 09077V100 09077V100 40,874,371 1,667,661 SH SOLE 1,667,661 0 0
Bright Minds Biosciences Inc 10919W405 10919W405 14,188,403 202,114 SH SOLE 202,114 0 0
Context Therapeutics Inc 21077P108 21077P108 719,542 1,299,046 SH SOLE 1,299,046 0 0
Corcept Therapeutics, Inc. 218352102 218352102 67,040,885 771,028 SH SOLE 771,028 0 0
Cullinan Therapeutics, Inc. 230031106 230031106 177,207,720 9,731,341 SH SOLE 9,731,341 0 0
DBV Technologies S A 23306J309 23306J309 60,127,058 3,666,284 SH SOLE 3,666,284 0 0
Dianthus Therapeutics Inc 252828108 252828108 40,941,795 420,002 SH SOLE 420,002 0 0
Dyne Therapeutics, Inc. 26818M108 26818M108 42,689,686 1,922,093 SH SOLE 1,922,093 0 0
Edgewise Therapeutics Inc 28036F105 28036F105 65,852,291 1,620,780 SH SOLE 1,620,780 0 0
Entrada Therapeutics, Inc. 29384C108 29384C108 9,222,470 1,253,053 SH SOLE 1,253,053 0 0
Forte Biosciences, Inc. 34962G208 34962G208 20,983,270 987,448 SH SOLE 987,448 0 0
Liquidia Corporation 53635D202 53635D202 110,519,653 1,386,174 SH SOLE 1,386,174 0 0
MoonLake Immunotherapeutics 61559X104 61559X104 31,287,647 1,606,967 SH SOLE 1,606,967 0 0
Monte Rosa Therapeutics Inc 61225M102 61225M102 28,098,160 1,161,081 SH SOLE 1,161,081 0 0
Natera Inc 632307104 632307104 25,146,585 92,638 SH SOLE 92,638 0 0
Oric Pharmaceuticals Inc 68622P109 68622P109 20,383,814 1,882,162 SH SOLE 1,882,162 0 0
Palvella Therapeutics Inc 697947109 697947109 31,179,406 204,027 SH SOLE 204,027 0 0
Relay Therapeutics Inc. 75943R102 75943R102 45,197,223 2,415,672 SH SOLE 2,415,672 0 0
Revolution Medicines, Inc. 76155X100 76155X100 92,232,216 492,483 SH SOLE 492,483 0 0
Stoke Therapeutics Inc 86150R107 86150R107 23,666,834 723,314 SH SOLE 723,314 0 0
Syndax Pharmaceuticals Inc 87164F105 87164F105 29,150,813 1,333,523 SH SOLE 1,333,523 0 0
Tarsus Pharmaceuticals Inc 87650L103 87650L103 20,267,121 322,007 SH SOLE 322,007 0 0
Taysha Gene Therapies, Inc. 877619106 877619106 30,645,000 4,500,000 SH SOLE 4,500,000 0 0
Travere Therapeutics Inc 89422G107 89422G107 63,782,348 1,122,731 SH SOLE 1,122,731 0 0
Trevi Therapeutics Inc 89532M101 89532M101 57,322,211 3,073,577 SH SOLE 3,073,577 0 0
Ultragenyx Pharmaceuticals, Inc. 90400D108 90400D108 47,354,199 1,418,215 SH SOLE 1,418,215 0 0
Uniqure NV N90064101 N90064101 56,462,881 1,225,855 SH SOLE 1,225,855 0 0
Urogen Pharma Ltd M96088105 M96088105 34,349,672 933,415 SH SOLE 933,415 0 0
Werewolf Therapeutics, Inc. 95075A107 95075A107 28,851 80,142 SH SOLE 80,142 0 0
Zura Bio Ltd. G9TY5A101 G9TY5A101 26,389,774 4,472,843 SH SOLE 4,472,843 0 0